Ángel R. L.
- Country
- Spain
- Department
- #2107: Oftalmología
Research Overview
- Evaluation of Satralizumab Efficacy and Safety in Moderate-to-Severe Thyroid Eye Disease: A Phase III Randomized, Double-Masked, Placebo-Controlled Study
- Efficacy, Safety, and Tolerability of VRDN-003 in Active Thyroid Eye Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
- Efficacy, Safety, and Tolerability of VRDN-003 in Chronic Thyroid Eye Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 16 of 43 partner sites.
Specializations
Ophthalmological Disorders
The investigator specializes in treating thyroid eye disease (TED), with particular emphasis on moderate to severe manifestations of this condition. Their research encompasses innovative therapeutic approaches for managing ocular symptoms associated with thyroid disorders.
- Proptosis management
- Orbital inflammation
- TED symptom control
Focuses on developing treatment strategies for patients with active thyroid eye disease using targeted biological therapies.
Immunological Research
Conducts studies involving monoclonal antibody treatments targeting specific receptors involved in thyroid eye disease pathogenesis. The investigator's work includes evaluation of novel biological agents for autoimmune orbital conditions.
- IGF-1 receptor targeting
- Subcutaneous biologics
- Immunomodulation therapy
Explores various dosing regimens and administration routes to optimize treatment outcomes.
Clinical Pharmacology
Investigates the pharmacokinetics and pharmacodynamics of novel therapeutic agents. Their research includes comprehensive evaluation of drug safety profiles and therapeutic efficacy in both healthy volunteers and patients.
- Drug tolerability assessment
- Dose optimization studies
- Treatment response monitoring
Examines different dosing intervals and administration protocols to enhance therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.